Differential behavioural effect of quinpirole in neuroleptic-pretreated rats - Role of α1-adrenoceptor

European Journal of Pharmacology

Volumn 384, Issue 2-3, 1999, Pages 101-109

  Obuchowicz, Ewa ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Behaviour; Neuroleptic induced supersensitivity; Prazosin; Quinpirole

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CHLORPROMAZINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; PRAZOSIN; QUINPIROLE; SULPIRIDE;

AGGRESSION; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; GROOMING; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REARING; SEXUAL BEHAVIOR; SUPERSENSITIVITY; VOCALIZATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CHLORPROMAZINE; DOPAMINE AGONISTS; DRUG SYNERGISM; HALOPERIDOL; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; PRAZOSIN; QUINPIROLE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; SODIUM CHLORIDE; SULPIRIDE;

EID: 0033430345     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00666-4     Document Type: Article

References (39)

1. Agmo A., Fernandez H. Dopamine and sexual behavior in the male rat: a reevaluation. J. Neural Transm. 77:1989;21-37.
2. 2+ channels. Eur. J. Pharmacol. 294:1995;459-467.
3. 2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmacol. Toxicol. 62:1988;121-130.
4. Carvey P.M., Hitri A., Goetz C.G., Tanner C.M., Klawans H.L. Concurrent treatment with benztropine and haloperidol attenuates development of behavioural hypersensitivity but not dopamine receptor proliferation. Life Sci. 42:1988;2207-2215.
5. 2 dopamine binding site up-regulation and apomorphine-induced stereotypy. Pharmacol. Biochem. Behav. 28:1987;477-482.
6. Clark J.T., Smith E.R., Davidson J.M. Evidence for the modulation of sexual behavior by alpha-adrenoceptors in male rats. Neuroendocrinology. 41:1985;36-43.
7. Clark J.T., Kalra S., Kalra P.S. Effects of a selective alpha 1-adrenoceptor agonist, methoxamine, on sexual behavior and penile reflexes. Physiol. Behav. 40:1987;747-753.
8. 2 receptors: implications for drug mechanisms of action. Life Sci. 39:1986;2571-2580.
9. 2 agonists induced by chronic treatment with imipramine. Pharmacol. Res. 25:1992;95-101.
10. Darracq L., Blanc G., Glowinski J., Tassin J.P. Importance of the noradrenaline-dopamine coupling in the locomotor-activating effects of D-amphetamine. J. Neurosci. 18:1998;2729-2739.
11. Dickinson S.L., Gadie B., Tulloch I.F. Alpha 1- and alpha 2-adrenoceptor antagonists differentially influence locomotor and stereotyped behaviour induced by D-amphetamine and apomorphine in the rat. Psychopharmacol. Berlin. 96:1988;521-527.
12. 2 agonist, LY171555 on oral movements in rats. Psychopharmacol. Berlin. 96:1988;253-257.
13. 2 agonist, quinpirole, produce locomotor stimulation in dopamine-depleted mice. Pharmacol. Toxicol. 67:1990;123-131.
14. 1 receptors. Biochem. Pharmacol. 32:1983;2921-2927.
15. Grenhoff J., Svensson T.H. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur. J. Pharmacol. 233:1993;79-84.
16. Grenhoff J., Nisell M., Ferre S., Aston-Jones G., Svensson T.H. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in rat. J. Neural Transm.: Gen. Sect. 93:1993;11-25.
17. Haller J., Makara G.B., Kruk M.R. Catecholaminergic involvement in the control of aggression: hormones, the peripheral sympathetic and central noradrenergic systems. Neurosci. Biobehav. Rev. 22:1998;85-97.
18. 3 receptors in rat brain. Psychopharmacology. 128:1996;362-370.
19. Jackson D.M., Dunstan R., Perrington A. The hyperkinetic syndrome following long-term haloperidol treatment: involvement of dopamine and noradrenaline. J. Neural Transm. 44:1979;175-186.
20. Kimura H., Yamada K., Nagashima M., Furukawa T. Involvement of catecholamine receptor activities in modulating the incidence of yawning in rats. Pharmacol. Biochem. Behav. 53:1996;1017-1021.
21. 2 synergism are unrelated to changes in striatal receptor density. Synapse. 12:1992;14-26.
22. 2 receptors. Psychopharmacology. 112:1993;S40-S54.
23. 2 agonists. J. Neural Transm. 76:1989;29-38.
24. 2 receptor attenuates haloperidol-induced behavioural supersensitivity and receptor up-regulation. Eur. J. Pharmacol. 231:1993;191-196.
25. McKenzie G.M. Apomorphine-induced aggression in the rat. Brain Res. 34:1971;323-330.
26. 2 agonists, LY 171555 and RU 24213. Life Sci. 42:1988;2561-2567.
27. 2 dopamine receptors. Life Sci. 44:1989;1019-1026.
28. 1-adrenergic system. A behavioral study with the clonidine-induced aggression test. Pol. J. Pharmacol. Pharm. 38:1986;529-534.
29. 2 interaction. Eur. J. Pharmacol. 160:1989;377-384.
30. 3 receptor-preferring agonist: comparison to other dopamine receptor agonists. Eur. J. Pharmacol. 312:1996;35-44.
31. Prosser E.S., Pruthi R., Csernansky J.G. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride. Psychopharmacol. Berlin. 99:1989;109-116.
32. Robbins T.W., Everitt B.J. Central norepinephrine neurons and behavior. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;363-372 Raven Press, New York.
33. Rubinstein M., Schinder A.F., Gershanik O., Stefano F.J.E. Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo- and supersensitive mice. Life Sci. 44:1989;337-346.
34. Schröder U., Schröder H., Augustin W., Sabel B.A. Haloperidol-induced behavioral supersensitivity is increased in rats by GM1 ganglioside treatment without affecting spiroperidol binding. J. Pharmacol. Exp. Ther. 271:1994;1193-1196.
35. Sommermeyer H., Frielingsdorf J., Knorr A. Effects of prazosin on the dopaminergic neurotransmission in rat brain. Eur. J. Pharmacol. 276:1995;267-270.
36. Szczypka M.S., Zhou Q.Y., Palmiter R.D. Dopamine-stimulated sexual behavior is testosterone-dependent in mice. Behav. Neurosci. 112:1998;1229-1235.
37. Waldmeier P.C., Ortmann R., Bischoff S. Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists. Experientia. 38:1982;1168-1176.
38. 2 agonist effects. Science. 236:1987;719-722.
39. 2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacol. Biochem. Behav. 30:1988;189-193.